Back to search

Article

Osimertinib resistance-based immune prognostic related gene signature in EGFR mutant lung adenocarcinoma, in which PSMD11 promotes tumor progression

2024-07-13

Abstract excerpt

<title>Abstract</title> <p>Background At present, epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) treatment, as the first-line treatment of lung adenocarcinoma (LUAD) with EGFR mutation, has achieved good clinical efficacy, but most patients will eventually develop acquired resistance. Therefore, there is an urgent need to develop a strong standard to identify drug-resistant patients with...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d7628789-c841-5b00-8515-517575332675
DOI
10.21203/rs.3.rs-4570660/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Osimertinib resistance-based immune prognostic related gene signature in EGFR mutant lung adenocarcinoma, in which PSMD11 promotes tumor progressionDOI 10.21203/rs.3.rs-4570660/v1
Integration of osimertinib-targeted EGFR gene-associated differential gene expression in constructing a prognostic model for lung adenocarcinomaSemantic proximity
Identification of an immune-related genes signature in lung adenocarcinoma to predict survival and response to immune checkpoint inhibitorsSemantic proximity
Identification of biomarkers, pathways and potential therapeutic targets for EGFR-TKI resistance in non-small-cell lung cancerSemantic proximity
Identification of an immune-related genes signature in lung adenocarcinoma to predict survival and response to immune checkpoint inhibitors.Semantic proximity
An immune gene signature to predict prognosis and immunotherapeutic response in lung adenocarcinomaSemantic proximity
Drug resistance related genes in lung adenocarcinoma predict patient prognosis and influence the tumor microenvironmentSemantic proximity
An Immune Gene Signature for Prediction of Overall Survival and Response to Immune Checkpoint Inhibitors Therapy in Patients with Lung AdenocarcinomaSemantic proximity
Development of an Immune-Related Gene Pairs Signature for Predicting Clinical Outcome in Lung AdenocarcinomaSemantic proximity
Development of an immune-related gene pairs signature for predicting clinical outcome in lung adenocarcinomaSemantic proximity
Clinical and Prognostic Implications of an Immune-Related Risk Model Based on TP53 Status in Lung AdenocarcinomaSemantic proximity
Identification of Immune-Related Genes and Construction of Metastasis Prediction Model for Non-Small Cell Lung CancerSemantic proximity
Identification of a gene signature closely related to immunosuppressive tumor microenvironment predicting prognosis of patients in EGFR mutant lung adenocarcinomaSemantic proximity
Select a neighboring publication to make it the new centre.